Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharmacology Test 4 > Cardiac Drugs > Flashcards

Cardiac Drugs Flashcards

1
Q

adenosine: class

A
  • antidysrhythmic
  • naturally occurring nucleotide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

adenosine: MOA

A
  • decreases automaticity of SA node and slows conduction thru AV node
  • inhibits cyclic AMP induced calcium influx, so suppresses calcium dependent action potentials in the SA and AV nodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

adenosine: Indication

A
  • termination of paroxysmal SVT–more emergent use
    • including Wolff Parkinson White Syndrome
  • test drug during stress test in cardiac cath lab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adenosine: SE

A
  • dyspnea (from bronchoconstriction)
  • hypoTN
  • facial flushing (from vasodilation)
  • chest comfort (from stimulation of pain receptors in the heart)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adenosine: ADRs

A
  • sinus bradycardia
  • seizures
  • stroke
  • MI
  • ventricular tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adenosine: nursing implications

A
  • ADRs/SEs are minimal and last less than 1 minute b/c the drug is cleared rapidly from the blood
  • asthma pts taking certain meds (ie. theophylline) need a larger dose of adenosine b/c those meds block adenosine Rs and even then the adenosine may not work
  • short half life (<10 sec), so must give by IV bolus
  • watch for orthostatic hypoTN and bronchospasm in asthmatics
  • 6 second flat line
  • hold arm above pt when administer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

digoxin: class

A
  • antidysrhythmic
  • cardiac glycoside
  • inotropic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

digoxin: MOA

A
  • positive inotropic actions: their ability to inc myocardial contractile force
    • can inc CO
    • works by inhibiting Na/K ATPase, so inhibits the uptake of K into the cell which inhibits Na moving out, so w/ each action potential, intracellular K declines, Na inc, and Ca inc, so promotes Ca accumulation in myocytes
  • dec conduction thru AV node by:
    • direct depressant effect on AV node
    • acting on CNS to inc parasympathetic impulses to AV node
  • dec automaticity of SA node by :
    • inc parasympathetic traffic to node
    • dec sympathetic traffic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

digoxin: indications

A
  • HF
  • control of dysrhythmias
    • SVT
  • atrial fibrillation/flutter: can slow ventricular rate by reducing atrial impulses thru AV node
  • ineffective against ventricular dysrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

digoxin: SEs

A
  • GI disturbances: anorexia, nausea, vomiting, discomfort
  • CNS: fatigue, visual disturbances
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

digoxin: ADRs

A
  • cardiotoxicity: dysrhythmias
    • risk inc by hypokalemia which can result from concurrent therapy with diuretics (thiazides and loop diuretics)
    • risk inc by presence of heart dz
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

digoxin: nursing implications

A
  • watch K+ levels especially in pts taking thiazide or loop diuretics
    • must be w/in normal ranges: 3.5-5.0 mEq/L
    • need to monitor these–digoxin toxicity
  • narrow therapeutic range, so need to keep range b/w 0.5-0.8 ng/mL
    • ​half life is 36-48 hours
  • make sure pts don’t double up on doses to compensate for missed dose
  • limit salt intake to 1500 mg/day
  • pts should avoid excess fluid
  • if drink alcohol, consume no more than 1 drink/day
  • help pts establish appropriate regular, mild exercise
  • teach pt to monitor pulse
    • HR must be over 60 bpm before administration
  • teach pt to monitor for signs of hypokalemia (muscle weakness)–inform doctor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

verapamil: class

A
  • antidysrhythmic
  • nondihydropyridine calcium channel blocker (class IV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

verapamil: MOA

A
  • slowing of SA nodal automaticity
  • delay of AV nodal conduction
  • reduction of myocardial contractility
  • blockade of peripheral arterioles which causes dilation and reduces arterial pressure
  • blockade of arteries and arterioles which inc coronary perfusion
  • vasodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

verapamil: indications

A
  • atrial fibrillation w/ RVR or flutter
    • b/c slow ventricular rate
  • AV nodal reentrant circuit
    • so terminates SVT–more long term than adenosine
  • essential HTN
  • angina pectoris
  • NOT effective against ventricular dysrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

verapamil: SEs

A
  • vasodilation–>hypoTN and peripheral edema, facial flushing, headache, dizziness
  • constipation
17
Q

verapamil: ADRs

A
  • bradycardia
  • AV block
  • heart failure
  • can exacerbate heart dysfunctions
18
Q

verapamil: nursing implications

A
  • contraindications: severe hypoTN, sick sinus syndrome, 2nd/3rd degree AV heart block
  • check BP, pulse, liver & kidney fcn before starting
  • can inc risk of digoxin toxicity–so watch K+ levels
  • if combine with beta blocker, it will inc risk of bradycardia, AV block, HF
  • can be given PO or IV, but PO undergoes extensive metabolism on first pass thru liver
  • do NOT consume grapefruit juice
  • monitor BP
  • inform pts about signs of cardiac effects and edema
  • tell pts that constipation can be minimized by inc fluids and fiber
19
Q

diltizem: class

A
  • antidysrhythmic
  • nondihydropyridine calcium channel blocker (class IV)
20
Q

diltizem: MOA

A
  • blocks Ca channel blockers in the heart and blood vessels
  • slowing of SA nodal automaticity
  • delay of AV nodal conduction
  • reduction of myocardial contractility
  • blockade of peripheral arterioles which causes dilation and reduces arterial pressure
  • blockade of arteries and arterioles which inc coronary perfusion
  • vasodilation
21
Q

diltizem: indications

A
  • atrial fibrillation w/ RVR or flutter
    • b/c slow ventricular rate
  • AV nodal reentrant circuit
    • so terminates SVT
  • essential HTN
  • angina pectoris
  • NOT effective against ventricular dysrhythmias
22
Q

diltizem: SEs

A
  • vasodilation–>hypoTN and peripheral edema, facial flushing, headache, dizziness
  • constipation, but LESS than verapamil
  • chronic eczematous rash in older adults
23
Q

diltizem: ADRs

A
  • bradycardia
  • AV block
  • heart failure
  • can exacerbate heart dysfunctions
24
Q

diltizem: nursing implications

A
  • contraindications: severe hypoTN, sick sinus syndrome, 2nd/3rd degree AV heart block
  • check BP, pulse, liver & kidney fcn before starting
  • need to watch pts that are receiving diltizem with digoxin or a beta blocker
  • can be given PO or IV, but PO undergoes extensive metabolism on first pass thru liver
  • do NOT consume grapefruit juice
  • monitor BP–b/c this drug will dec BP
  • inform pts about signs of cardiac effects and edema
  • tell pts that constipation can be minimized by inc fluids and fiber
25
amiodarone: class
* antidysrhythmic * potassium channel blocker (class III)
26
amiodarone: MOA (PO)
* delays repolarization so prolongs action potential and ERP * effects may be due to blockage of potassium channels * reduced automaticity of SA node * reduced contractility * reduced conduction velocity of AV node, ventricles, His Purkinje fibers * promote dilation in coronary and peripheral blood vessels
27
amiodarone: SE (PO)
* dyspnea * cough * corneal microdeposits * photosensitivity * CNS effects: ataxia, dizziness, tremor, hallucinations, mood alterations * GI disturbances: nausea, vomiting, anorexia
28
amiodarone: ADRs (PO)
* lung damage (biggest concern) * hypersensitivity pneumonitis * interstitial/alveolar pneumonitis * pulmonary fibrosis * paradoxical inc in dysrhythmic activity * sinus bradycardia * AV block * HF * hypo/hyperthyroidism * liver injury: malaise, dark urine, fatigue, jaundice * optic neuropathy * neuritis
29
amiodarone: nursing implications (PO)
* contraindicated for pts w/ severe sinus node dysfunction, 2nd/3rd degree heart block, pregnant women, preexisting HF * very toxic so only give to pts who haven't responded to safer drugs * toxicity can continue for weeks or months after withdrawal, so patient must be given medication guide * baseline chest x ray and pulmonary fcn * monitor throughout therapy * baseline thyroid fcn * monitor throughout therapy * baseline liver fcn * monitor throughout therapy * do not give to pregnant women or women who are breast feeding b/c lipid soluble (so crosses placenta and enters breast milk) * avoid sunlamps, wear sunscreen * do NOT consume grapefruit juice, b/c can cause toxicity * report any signs of changes in visual acuity
30
amiodarone: indications (IV)
* tx and prophylaxis of recurrent ventricular fibrillation * hemodynamically unstable ventricular tachycardia * unapproved uses: * atrial fibrillation * AV nodal reentrant tachycardia * shock resistant ventricular fibrillation
31
dronedarone: Indications
* **atrial flutter, fibrillation** * **also give to pts in sinus rhythm with a history of paroxysmal or persistent afib**
32
dronedarone: MOA
* blocks cardiac potassium channels so delays repolarization * can block Na channels, beta adrenergic receptors, and calcium channels
33
dronedarone: class
* antidysrythmic * potassium channel blocker (class III)
34
dronedarone: SE
* diarrhea * weakness * nausea * skin rxns * sensitivity to light' * abdominal pain
35
dronedarone: nursing implications
* teach pts signs of liver toxicity: anorexia, nausea, vomiting, malaise, fatigue, itching, jaundice, dark urine * cannot use in pregnancy b/c proven teratogen * category X * do NOT consume grapefruit juice

Pharmacology Test 4 (10 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions